Close Menu

NEW YORK (GenomeWeb) – Rennova Health said today that it has acquired the 85 percent stake in pharmacogenetics testing firm Genomas that it did not already own.

Hartford, Connecticut-based Genomas has developed and offers the PhyzioType System for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease and diabetes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.